BRANGANI, Corinna
 Distribuzione geografica
Continente #
EU - Europa 1.141
NA - Nord America 658
AS - Asia 207
AF - Africa 6
SA - Sud America 3
OC - Oceania 1
Totale 2.016
Nazione #
GB - Regno Unito 737
US - Stati Uniti d'America 649
CN - Cina 170
IT - Italia 142
SE - Svezia 64
IE - Irlanda 56
FI - Finlandia 40
FR - Francia 37
DE - Germania 35
KR - Corea 18
VN - Vietnam 11
GR - Grecia 8
CA - Canada 7
UA - Ucraina 7
BE - Belgio 5
GH - Ghana 5
BR - Brasile 3
NL - Olanda 3
TR - Turchia 3
AL - Albania 2
IN - India 2
IR - Iran 2
MX - Messico 2
CZ - Repubblica Ceca 1
LU - Lussemburgo 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PL - Polonia 1
RO - Romania 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 2.016
Città #
Southend 711
Chandler 129
Houston 62
Ashburn 61
Dublin 56
Beijing 55
Ann Arbor 54
Woodbridge 49
Verona 39
Jacksonville 35
New York 29
Wilmington 29
Jinan 20
Helsinki 17
Lawrence 17
Princeton 17
Nanjing 15
Dearborn 13
Seoul 12
Lancaster 11
Hebei 10
Milan 9
Redmond 9
Nikaia 8
Ningbo 8
Dong Ket 7
Nanchang 7
Hangzhou 6
Shenyang 6
Accra 5
Brussels 5
Changsha 5
Taizhou 5
Treviso 5
Washington 5
Zhengzhou 5
Cagliari 4
Falls Church 4
Seattle 4
Sindelfingen 4
Toronto 4
Yongin-si 4
Auburn Hills 3
Bologna 3
Fuzhou 3
Kitchener 3
Lido di Spina 3
Los Angeles 3
Napoli 3
San Paolo 3
Taiyuan 3
Alcamo 2
Boardman 2
Catanzaro 2
Chengdu 2
Chicago 2
Coventry 2
Haikou 2
Lübeck 2
Redwood City 2
Tehran 2
Tirana 2
Trento 2
Vigevano 2
Apodaca 1
Arzignano 1
Auckland 1
Avola 1
Bengaluru 1
Cambridge 1
Cardano 1
Catania 1
Clearwater 1
Cosenza 1
Crotone 1
Desio 1
Dongguan 1
Downers Grove 1
Düsseldorf 1
Fairfield 1
Floridia 1
Groningen 1
Guangzhou 1
Icheon-si 1
Irving 1
Jesi 1
Johannesburg 1
Katowice 1
Kochi 1
Kunming 1
Luxembourg 1
Melfi 1
Mentana 1
Naples 1
Novara 1
Orta di Atella 1
Palermo 1
Prague 1
Prato 1
Qingdao 1
Totale 1.649
Nome #
American Diabetes Association 75th Scientific Meeting - Epidemiology/Genetics Section; Poster 1563-P: Pancreatic Beta-Cell Function, Insulin Sensitivity, and Metabolic Phenotypes in Type 2 Diabetes at the Time of Diagnosis—The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 601
Quantificazione del ruolo svolto dai principali fattori determinanti la glicemia durante un pasto misto, nei pazienti affetti da diabete mellito tipo 1 in terapia con microinfusore insulinico associato a glucosensore 130
Metabolic Effects of Exercise 125
"Presence and titer of GAD antibodies are determinants of beta cell function in patients with newly diagnosed type 2 diabetes mellitus: further insights in the metabolic phenotype of LADA patients" 119
Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: Impact on cardiovascular events. A randomized controlled trial. 116
Lower levels of 25-hydroxyvitamin D3 are associated with a higher prevalence of microvascular complications in patients with type 2 diabetes. 100
Glycated haemoglobin is inversely related to serum vitamin d levels in type 2 diabetic patients. 99
Prevalence of neuropathy in type 2 diabetic patients and its association with other diabetes complications: The Verona Diabetic Foot Screening Program. 91
A Novel Insulin/Glucose Model after a Mixed-Meal Test in Patients with Type 1 Diabetes on Insulin Pump Therapy 89
Prevalence of Cardiovascular Autonomic Neuropathy in a Cohort of Patients With Newly Diagnosed Type 2 Diabetes: The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 89
Relationship of Chronic Vascular Complications with Beta-Cell Dysfunction and Insulin Resistance in Newly Diagnosed Type 2 Diabetes: The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 88
A parsimonious model of a mixed-meal test in patients with type 1 diabetes in insulin pump therapy 83
Gli iperandrogenismi nella donna in post-menopausa 83
Interleukin-6 as a potential positive modulator of human beta-cell function: an exploratory analysis-the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 6 75
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 74
Chronic complications in patients with newly diagnosed type 2 diabetes: prevalence and related metabolic and clinical features: the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 9 58
Glomerular filtration rate decline in T2DM following diagnosis. The Verona newly diagnosed diabetes study-12 36
Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion 19
Totale 2.075
Categoria #
all - tutte 5.132
article - articoli 2.972
book - libri 0
conference - conferenze 1.561
curatela - curatele 0
other - altro 287
patent - brevetti 0
selected - selezionate 0
volume - volumi 312
Totale 10.264


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201935 0 0 0 0 0 0 0 0 0 0 16 19
2019/2020349 32 21 20 24 35 35 27 18 16 53 32 36
2020/2021291 26 34 23 32 32 27 14 18 20 17 24 24
2021/2022218 29 54 15 16 16 17 7 14 8 4 14 24
2022/2023349 29 55 21 52 31 87 3 21 31 4 7 8
2023/2024230 10 22 17 24 23 67 7 19 4 35 2 0
Totale 2.075